US News

Pill Version of Weight-Loss Drug Wegovy Approved by US Regulator

U.S.-listed shares of Novo jumped by 8 percent while Lilly fell by 1 percent in trading after the approval was announced.
Pill Version of Weight-Loss Drug Wegovy Approved by US Regulator
The logo of Danish pharmaceutical company Novo Nordisk at its headquarters in Bagsvaerd, Denmark, on Feb. 1, 2017. Liselotte Sabroe/Scanpix Denmark/AFP via Getty Images
Rachel Roberts
|Updated:
0:00
U.S. regulators have green-lit a pill version of the weight-loss drug Wegovy, making an oral version of the so-called “skinny jabs” available for the first time.

The Food and Drug Administration approved the pill made by Scandinavian pharmaceutical company Novo Nordisk, giving it the edge over American rival Eli Lilly in the race to bring an anti-obesity pill to market.

Rachel Roberts
Rachel Roberts
Author
Rachel Roberts is a London-based journalist with a background in local then national news. She focuses on health and education stories and has a particular interest in vaccines and issues impacting children.